14-day Premium Trial Subscription Try For FreeTry Free
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Allakos's Lirentelimab Flunks Late-Stage Studies In Patients With Inflammation In Digestive Tract Alla
Acuitas Investments LLC increased its holdings in shares of Repro Med Systems, Inc. (NASDAQ:KRMD) by 33.9% during the third quarter, Holdings Channel reports. The fund owned 250,342 shares of the company’s stock after purchasing an additional 63,321 shares during the period. Acuitas Investments LLC’s holdings in Repro Med Systems were worth $713,000 at the end […]
Adirondack Retirement Specialists Inc. increased its position in shares of Repro Med Systems, Inc. (NASDAQ:KRMD) by 206.1% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 174,501 shares of the companys stock after acquiring an additional 117,484 shares during the period. Repro Med Systems []
Vanguard Group Inc. decreased its stake in shares of Repro Med Systems, Inc. (NASDAQ:KRMD) by 20.6% during the second quarter, according to its most recent filing with the SEC. The institutional investor owned 1,358,412 shares of the companys stock after selling 352,560 shares during the period. Vanguard Group Inc.s holdings in Repro Med Systems were []
Repro Med Systems, Inc. (KRMD) CEO Linda Tharby on Q3 2021 Results - Earnings Call Transcript
Repro Med Systems, Inc. (KRMD) delivered earnings and revenue surprises of 33.33% and 10.44%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the s
Repro Med Systems, Inc. (KRMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
KORU Medical Systems, Inc. (KRMD) CEO Linda Tharby on Q2 2021 Results - Earnings Call Transcript
Repro Med Systems, Inc. (KRMD) delivered earnings and revenue surprises of 33.33% and 10.34%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
New York, New York--(Newsfile Corp. - May 25, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Repro Med Systems, Inc. (NASDAQ: KRMD) alle
New York, New York--(Newsfile Corp. - May 25, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Rep
Los Angeles, California--(Newsfile Corp. - May 25, 2021) -  The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Repro Med Systems,
NEW YORK, May 25, 2021 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Repro Med Systems, Inc. d/b/a KORU Medical Systems ("KORU" or the "Company") (NASDAQ:
LOS ANGELES--(BUSINESS WIRE)---- $KRMD #investors--The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against KORU Medical Systems (KRMD)
Los Angeles, California--(Newsfile Corp. - May 24, 2021) -  The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Repro Med Systems,
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE